Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-10-054924PMID 17234738PMCID PMC1885508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

  2007cited by this paper
• SNAP-23 and syntaxin-2 localize to the extracellular surface of the platelet plasma membrane.

  2007cited by this paper
• Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem-cell transplantation.

  2007cited by this paper
• Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A

  2007cited by this paper
• Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.

  2006cited by this paper
• Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction.

  2006cited by this paper
• A Clamping Mechanism Involved in SNARE-Dependent Exocytosis

  2006cited by this paper
• Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.

  2006cited by this paper
• Iron-overload in long-term survivors of hematopoietic transplantation

  2006cited by this paper
• Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients

  2006cited by this paper
• Environmental risk factors for inhibitor development in children with haemophilia A: a case–control study

  2005cited by this paper
• Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

  2005cited by this paper
• The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation

  2005cited by this paper
• Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy

  2004cited by this paper
• A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

  2004cited by this paper
• The epidemiology of inhibitors in haemophilia A: a systematic review

  2003cited by this paper
• Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia

  2003cited by this paper
• Fusion of Cells by Flipped SNAREs

  2003cited by this paper
• Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation

  2002cited by this paper
• Acute promyelocytic leukemia with a PLZF-RARα fusion protein

  2001cited by this paper
• Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease.

  2001cited by this paper
• BMT: Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study.

  2000cited by this paper
• Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study.

  1999cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Secondary hemochromatosis as a long‐term complication of the treatment of hematologic malignancies

  1999cited by this paper
• Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.

  1998cited by this paper
• Iron overload following bone marrow transplantation in children: MR findings

  1997cited by this paper
• Marrow transplantation for patients with thalassemia: results in class 3 patients.

  1996cited by this paper
• Survival in Medically Treated Patients with Homozygous β-Thalassemia

  1994cited by this paper
• Survival in medically treated patients with homozygous beta-thalassemia.

  1994cited by this paper
• Marrow transplantation in patients with thalassemia responsive to iron chelation therapy.

  1993cited by this paper
• Bone marrow transplantation in adult thalassemia.

  1992cited by this paper
• Bone marrow transplantation in patients with thalassemia.

  1990cited by this paper

• Matched Unrelated Donor (MUD) Transplants Show Promising Outcomes in Thalassemia Patients Aged ≤ 12 Years.

  2026cites this paper
• Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients

  2025cites this paper
• Transfusion-related iron overload in survivors of childhood cancer.

  2025cites this paper
• Effect of Serum Ferritin Level on the Response to Standard Chemotherapy in Acute Myeloid Leukemia Patients

  2025cites this paper
• Causal association between iron status and heart failure: A 2-sample bidirectional Mendelian randomization study

  2025cites this paper
• Burden beyond the cure: Iron overload following pediatric stem cell transplantation.

  2025cites this paper
• Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance.

  2025cites this paper
• Concentration of serum trace elements in leukemia and lymphoma: A case-control study

  2024cites this paper
• Navigating ‘grey areas’ and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT

  2024cites this paper
• Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions

  2024cites this paper
• Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.

  2024cites this paper
• Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.

  2024cites this paper
• Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP).

  2024cites this paper
• The impact of granulocyte colony-stimulating factor and decitabine-containing conditioning in myelodysplastic syndrome patients with iron overload undergoing allogeneic hematopoietic stem cell transplantation: a retrospective study

  2024cites this paper
• Alteration of Maternal Serum Ferritin in Pregnancy and Maternal-fetal Infections: A retrospective cohort study

  2024cites this paper
• Retrospective Evaluation of Patients Who Underwent Allogeneic Stem Cell Transplantation for Bone Marrow Failure

  2023cites this paper
• Does ferritin level affect the outcomes of autologous stem cell transplantation equally in all diseases?

  2023cites this paper
• Soluble Hemojuvelin and Ferritin: Potential Prognostic Markers in Pediatric Hematopoietic Cell Transplantation

  2023cites this paper
• The impact of pretransplant serum ferritin on haploidentical hematopoietic stem cell transplant for acquired severe aplastic anemia in children and adolescents

  2022cites this paper
• Longitudinal proteomics study of serum changes after allogeneic HSCT reveals potential markers of metabolic complications related to aGvHD

  2022cites this paper
• Serum albumin and ferritin levels: a practical indicator of prognosis in acute myeloid leukemia over 50 years of age?

  2022cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single Centre Experience in Malaysia

  2022cites this paper
• Hepcidin in Children and Adults with Acute Leukemia or Undergoing Hematopoietic Cell Transplantation: A Systematic Review

  2022cites this paper
• Iron overload in the HCT patient: a review

  2021cites this paper
• Room for Improvement: A 20-Year Single Center Experience with Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes

  2021cites this paper
• Posicionamento Brasileiro sobre o Uso da Multimodalidade de Imagens na Cardio-Oncologia – 2021

  2021cites this paper
• Role of Iron in Cancer.

  2021cites this paper
• Efficacy and Safety of Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Thalassemia Patients: A Retrospective Observational Study

  2021cites this paper
• Unbalance in Iron Metabolism in Childhood Leukemia Converges with Treatment Intensity: Biochemical and Clinical Analysis

  2021cites this paper
• British Society for Haematology guidelines for the management of adult myelodysplastic syndromes

  2021cites this paper
• Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia

  2021cites this paper
• Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine

  2021cites this paper
• The Role of Iron in Benign and Malignant Hematopoiesis

  2020cites this paper
• Indications for Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome

  2020cites this paper
• Iron Overload is Associated with Delayed Engraftment and Increased Non-Relapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation.

  2020cites this paper
• Treatment Algorithms for Lower-Risk Myelodysplastic Syndrome

  2020cites this paper
• Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria

  2020cites this paper
• Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2020influential citation
• How we manage adults with myelodysplastic syndrome

  2020cites this paper
• Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome

  2020cites this paper
• The prevalence and associated mortality of non‐anaemic iron deficiency in older adults: a 14 years observational cohort study

  2020cites this paper
• Busulfan clearance does not predict the development of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation

  2020cites this paper
• Hyperferritinemia and acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation

  2020cites this paper
• Current and emerging strategies for management of myelodysplastic syndromes.

  2020cites this paper
• Myelodysplastic Syndromes

  2020cites this paper
• Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell Transplant.

  2020cites this paper
• Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma

  2020cites this paper
• Assessment of older adult candidates for allogeneic hematopoietic cell transplantation: updates and remaining questions

  2019cites this paper
• Improved survival outcomes and restoration of graft‐vs‐leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia

  2019cites this paper
• In myelodysplastic syndrome cases, what should be the level of ferritin which has prognostic value?

  2019cites this paper
• Iron and leukemia: new insights for future treatments

  2019cites this paper
• Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients

  2019cites this paper
• Iron Toxicity and Hemopoietic Cell Transplantation: Time to Change the Paradigm

  2019cites this paper
• Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies.

  2019cites this paper
• Application of standard and novel prognostic systems in patients with myelodys- plastic syndrome undergoing allogeneic hematopoietic stem cell transplantation

  2019cites this paper
• Allogeneic Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome

  2019cites this paper
• Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes

  2019cites this paper
• Allogeneic stem cell transplant in myelodysplastic syndrome‐factors impacting survival

  2019cites this paper
• The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML

  2019cites this paper
• Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60–69 years with myelodysplastic syndrome

  2019cites this paper
• Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia

  2018cites this paper
• Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?

  2018cites this paper
• Title Clinical Significance of Serum Hepcidin Levels on Early Infectious Complications in Allogeneic Hematopoietic Stem Cell Transplantation

  2018influential citation
• Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine.

  2018cites this paper
• Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

  2018cites this paper
• Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation

  2018cites this paper
• AML: high serum ferritin at initial diagnosis has a negative impact on long-term survival

  2018influential citation
• Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia

  2018cites this paper
• Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform

  2018cites this paper
• Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study

  2018cites this paper
• Pretransplant C-reactive protein, ferritin, albumin, and platelet count as prognostic biomarkers of hematopoietic stem cell transplantation outcome in hematological malignancies

  2018cites this paper
• Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia

  2017cites this paper
• Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning

  2017cites this paper
• TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

  2017cites this paper
• Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies.

  2017cites this paper
• The Glasgow Prognostic Score as a pre‐transplant risk assessment for allogeneic hematopoietic cell transplantation

  2017cites this paper
• Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

  2017cites this paper
• Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies

  2017cites this paper
• Iron chelation therapy in low risk myelodysplastic syndrome

  2017cites this paper
• Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?

  2017cites this paper
• Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends

  2017cites this paper
• Factors affecting hematopoietic stem cell mobilization and apheresis in allogeneic donors: The role of iron status.

  2017cites this paper
• The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress

  2017cites this paper
• Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients

  2017cites this paper
• ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia.

  2017cites this paper
• From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation.

  2017cites this paper
• Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection

  2017cites this paper
• Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation

  2017cites this paper
• Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT.

  2017cites this paper
• Supportive Care in Aplastic Anemia

  2017cites this paper
• Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later

  2017cites this paper
• Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT)

  2017cites this paper
• Cord blood chimerism and relapse after haplo-cord transplantation

  2017cites this paper
• Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Guideline Aplastic Anemia-Diagnos tics and Therapy of Acquired Aplastic Anemia

  2016cites this paper
• Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

  2016cites this paper
• [Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)].

  2016cites this paper
• Disruption of Iron Regulation after Radiation and Donor Cell Infusion.

  2016cites this paper
• Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation

  2016cites this paper
• High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation

  2016cites this paper
• Iron Overload in Survivors of Childhood Cancer

  2016cites this paper